Stockreport

UniQure's AMT-060 shows treatment benefit in hemophilia B patients with pre-existing neutralizing antibodies; shares up 3% [Seeking Alpha]

uniQure N.V. - Ordinary Shares  (QURE) 
Last uniqure n.v. - ordinary shares earnings: 4/29 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: uniqure.com/investors-newsroom/overview.php
PDF UniQure's AMT-060 shows treatment benefit in hemophilia B patients with pre-existing neutralizing antibodies; shares up 3%Are-analysis of pretreatment blood samples from [Read more]